Nevertheless, studies in the stroke subtype, subarachnoid hemorrhage, have demonstrated that inhibiting the AMPK signaling can reverse the tissue and cellular ischemic injuries mediated by C-176, a specific STING agonist. Here, STING1 is linked to stroke disorder.